Co-clinical director, MGH Diabetes Center
Endocrinology
Dr. Deborah J. Wexler, MD
|
|
Give Review
Deborah J. Wexler is an expert in the field of Endocrinology. She graduated from Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care She has 1 awards "Regional Top Doctor". Deborah J. Wexler is a published doctor. She has 45 publications published. The most current publication "Can Canada afford type of care afforded to MP?" Deborah J. Wexler accepts all Medicare patients.
Publications
- Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk.
- Glycemic control after hospital discharge in insulin-treated type 2 Diabetes: a randomized pilot study of daily remote glucose monitoring.
- Material need support interventions for Diabetes prevention and control: a systematic review.
- Material Need Insecurities, Control of Diabetes Mellitus, and Use of Health Care Resources: Results of the Measuring Economic Insecurity in Diabetes Study.
- Individualizing HbA1c targets for patients with Diabetes: impact of an automated algorithm within a primary care network.
- A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 Diabetes.
- Age at type 2 Diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010.
- Positive Psychological Characteristics in Diabetes: A Review.
- Lower blood pressure associated with higher mortality in retrospective study of patients with newly diagnosed type 2 Diabetes.
- Pathways to quality inpatient management of hyperglycemia and Diabetes: a call to action.
- Food Insecurity and Metabolic Control Among U.S. Adults With Diabetes.
- Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
- Validity of medication adherence self-reports in adults with type 2 Diabetes.
- The differential associations of depression and Diabetes distress with quality of life domains in type 2 Diabetes.
- Intensification of Diabetes medication and risk for 30-day readmission.
- Impact of inpatient Diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.
- Effect of Hospital Admission on Glycemic Control One Year after Discharge.
- Taking AIM at a Moving Target: The Challenge of Improving on High-Performance Care.
- Diabetes Differentially Affects Depression and Self-Rated Health by Age in the U.S.
- High Rate of Placental Infarcts in Type 2 Compared with Type 1 Diabetes.
- Basal-bolus insulin protocols enter the computer age.
- Effectiveness of a computerized insulin order template in general medical inpatients with type 2 Diabetes: a cluster randomized trial.
- Dietary intake of eicosapentaenoic and docosahexaenoic acid and diabetic nephropathy: cohort analysis of the Diabetes control and complications trial.
- Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of Diabetes.
- Depression, self-care, and medication adherence in type 2 Diabetes: relationships across the full range of symptom severity.
- How doctors choose medications to treat type 2 Diabetes: a national survey of specialists and academic generalists.
- Prevalence of hyper- and hypoglycemia among inpatients with Diabetes: a national survey of 44 U.S. hospitals.
- Mediating effects of inflammatory biomarkers on insulin resistance associated with Obesity.
- Sex disparities in treatment of cardiac risk factors in patients with type 2 Diabetes.
- The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes.
- The Association of Maximum Body Weight on the Development of Type 2 Diabetes and Microvascular Complications: MAXWEL Study.
- Intensive dietary advice significantly improves HbA(1c) in patients with type II Diabetes who remain hyperglycaemic despite optimised drug treatment.
- Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 Diabetes pharmacogenetic testing.
- Inpatient Diabetes management in general medical and surgical settings: evidence and update.
- Association of diet with glycated hemoglobin during intensive treatment of type 1 Diabetes in the Diabetes Control and Complications Trial.
- Inpatient Diabetes management in non-ICU settings: evidence and strategies.
- Low risk of depression in Diabetes? Would that it were so.
- Association of Diabetes-related emotional distress with Diabetes treatment in primary care patients with Type 2 Diabetes.
- An algorithm for the care of type 2 Diabetes.
- Symptoms of depression prospectively predict poorer self-care in patients with Type 2 Diabetes.
- Correlates of health-related quality of life in type 2 Diabetes.
- Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary gl...
- Update in Diabetes and cardiovascular disease: synthesizing the evidence from recent trials of glycemic control to prevent cardiovascular disease.
- Can Canada afford Type of care afforded to MP?
Schools
Yale University
Massachusetts General Hospital
Massachusetts Genl Hospital
Conditions Treated
- Calcium Metabolism Disorders
- Diabetes Type 1
- Diabetes Type 2
- Goiter
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Massachusetts General Hospital -
Yale University School of Medicine
Hospital
-
Newton-Wellesley Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1730179342 | |
| NPPES Provider LastName | WEXLER | |
| NPPES Provider FirstName | DEBORAH | |
| NPPES Provider ZIPCode | 021142517 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 381.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 2.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730179342 |
| Last Name Of The Provider | WEXLER |
| First Name Of The Provider | DEBORAH |
| View All |
Similar Doctors
|
|
Dr. Marc N. Wein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amit R. Majithia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trevor E. Angell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mala S. Sivanandy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhiheng He, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nikolaos A. Stathatos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald A. Arky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Talia N. Herman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajaa Nahra, MD
This Doctor is OpenDoctor Recommended.
|